article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. These narratives have vilified individuals who would benefit from comprehensive, person-centered substance use treatment, rather than incarceration and other adverse harms.

article thumbnail

EMS Intervention to Reduce Falls: Carmen Quatman and Katie Quatman-Yates

GeriPal

Wait, first of all, what’s the incidence of calling EMS for falls over almost a decade, I think like 2007 to 2016, and what happens to people afterwards? All of these are factors that are on the individual level. Eric: So you both published a paper in JAGS, what, 2018, ’19 looking at what happens to people? Eric: Yeah.

Community 114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dementia and high risk surgery: Joel Weissman and Samir Shah

GeriPal

Eric: So we’re going to be talking about dementia and considerations around surgery for individuals with dementia. Eric: And what do we know about the outcomes of individuals getting these procedures, especially those with cognitive issues and dementia. That provision was taken out of Obamacare back in 2007, 2008.

article thumbnail

RCT of PC in ED: Corita Grudzen, Fernanda Bellolio, & Tammie Quest

GeriPal

I think that study was really important, especially I think the message that I give people is you can do something as simple as calling a consultation and improve quality of life months later. Now, some of the other secondary things, you know, you may have have seen if it was trigger of specialty palliative care consultations.

article thumbnail

FDA-Approved Labeling: Is Enough Enough?

FDA Law Blog

FDA did, however, try to identify safety issues through the medical literature and (after 2007 when mandatory safety reporting for OTC human drug products marketed without an approved application became effective) through the adverse event reporting system. A recent state law failure-to-warn case in the SDNY makes that very point.